Atai Beckley Inc.
Status: Publicly traded
Direct answer
Atai Beckley Inc. is publicly traded on NASDAQ under the ticker ATAI.
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally...
Can you invest in Atai Beckley Inc.?
Yes. Atai Beckley Inc. is publicly traded on NASDAQ under the ticker ATAI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Atai Beckley Inc.
Detailed equity research is provided by MarketSnap.